N | TEAEs | Treatment-related TEAEs | Gastrointestinal disordersa | |
---|---|---|---|---|
Without NSAIDs | 72 | 46 (63.9%) | 5 (6.9%) | 1 (1.4%) |
With NSAIDs | 94 | 80 (85.1%) | 10 (10.6%) | 1 (1.1%) |
N | TEAEs | Treatment-related TEAEs | Events at injection site | |
Without HA | 112 | 83 (74.1%) | 12 (10.7%) | 14 (12.5%) |
With HA for ≤24 weeks | 30 | 23 (76.7%) | 2 (6.7%) | 1 (3.3%) |
With HA for > 24 weeks | 24 | 20 (83.3%) | 1 (4.2%) | 3 (12.5%) |